Our interactive GLP global map explains the status of each country’s regulations for human and agricultural gene editing and gene drives.
Anti-GMO Advocacy Funding Tracker
This GLP project maps contributions by foundations to anti-biotech activists and compares it to pro-GMO industry spending.
Linda Johnson
Articles written for the GLP list the source as Genes and Science. All other articles were written for the sources noted with excerpts provided by the GLP.
U.S. regulators rejected [Biomarin’s] potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime ...